Contegra (R) pulmonary valved conduit for the correction or reconstruction of the outflow tract of the right ventricle in congenital heart malformations in patients aged under 18

Parrella, A, Merlin, T
Record ID 32006000600
English
Authors' results and conclusions: The available level III-2 evidence indicates this technology is potentially safe and effective in the short term, although there is uncertainty regarding its safety and effectiveness in the long-term. The target group for this technology in Australia is small.
Authors' recommendations: HealthPACT recommends that this technology be monitored.
Details
Project Status: Completed
Year Published: 2004
URL for published report: Not Available
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Adolescent
  • Bioprosthesis
  • Child
  • Heart Valve Prosthesis
  • Heart Defects, Congenital
  • Ventricular Outflow Obstruction
Contact
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name: ahta@adelaide.edu.au
Contact Email: ahta@adelaide.edu.au
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.